Both clinical cohorts and preclinical models confirm TAMs as dominant immune constituents within ESCC ecosystems13, with PD-L1+ TAMs subsets inducing CD8+ T cell exhaustion through direct ligand-receptor interactions in tumor nests and draining lymph nodes14. Here, CD8A is linked to neoplasm.